Movatterモバイル変換


[0]ホーム

URL:


 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Section
Special Issue
Volume
Issue
Number
Page
 
Logical OperatorOperator
Search Text
Search Type
 
add_circle_outline
remove_circle_outline
 
 
Journals
Cells

Journal Description

Cells

Cells is an international, peer-reviewed, open access journal on cell biology, molecular biology, and biophysics, published semimonthly online by MDPI. TheNordic Autophagy Society (NAS) and the Spanish Society of Hematology and Hemotherapy (SEHH) are affiliated withCells and their members receive discounts on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed withinScopusSCIE (Web of Science),PubMed,MEDLINE,PMC,CAPlus / SciFinder, andother databases.
  • Journal Rank: JCR - Q2 (Cell Biology) / CiteScore - Q1 (General Biochemistry, Genetics and Molecular Biology)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 16 days after submission; acceptance to publication is undertaken in 2.7 days (median values for papers published in this journal in the first half of 2025).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
  • Sections: published in 21topical sections.
  • Companion journal: Organoids.
Impact Factor: 5.2 (2024); 5-Year Impact Factor: 6.1 (2024)

Latest Articles

24 pages, 4756 KiB  
Review
Mechanistic Insights into Autophagy-Dependent Cell Death (ADCD): A Novel Avenue for Cancer Therapy
byMd Ataur Rahman,Maroua Jalouli,Mohammed Al-Zharani,Ehsanul Hoque Apu andAbdel Halim Harrath
Cells2025,14(14), 1072; https://doi.org/10.3390/cells14141072 (registering DOI) - 13 Jul 2025
Abstract
Autophagy-dependent cell death (ADCD) presents a promising but challenging therapeutic strategy in cancer treatment. Autophagy regulates cellular breakdown and stress responses, serving a dual function—either inhibiting tumorigenesis or facilitating the survival of cancer cells in advanced stages. This paradox presents both opportunities and [...] Read more.
Autophagy-dependent cell death (ADCD) presents a promising but challenging therapeutic strategy in cancer treatment. Autophagy regulates cellular breakdown and stress responses, serving a dual function—either inhibiting tumorigenesis or facilitating the survival of cancer cells in advanced stages. This paradox presents both opportunities and challenges in the exploration of autophagy as a potential target for cancer treatment. In this review, we explore various pharmacological agents, including autophagy inhibitors (e.g., chloroquine, 3-MA) and activators (e.g., rapamycin, metformin), which have demonstrated effectiveness in modulating autophagy-dependent cell death (ADCD). These agents either enhance cancer cell apoptosis or sensitize tumors to conventional therapies. Combination therapies, such as the use of autophagy modulators alongside chemotherapy, immunotherapy, or radiation therapy, offer enhanced therapeutic potential by overcoming drug resistance and improving overall treatment efficacy. Nonetheless, significant challenges remain, including tumor heterogeneity, treatment resistance, and off-target effects of autophagy-targeting agents. Future progress in biomarker discovery, precision medicine, and targeted medication development will be crucial for enhancing ADCD-based methods. Although autophagy-dependent cell death presents significant potential in cancer treatment, additional studies and clinical validation are necessary to confirm its position as a conventional therapeutic approach. Therefore, this review aims to identify the existing restrictions that will facilitate the development of more effective and personalized cancer therapies, hence enhancing patient survival and outcomes.Full article
(This article belongs to the Special IssueCell Death: Cell–Cell Interactions and Signaling Networks)
Show Figures

Figure 1

12 pages, 2505 KiB  
Article
The Expression ofShmt Genes in Amphioxus Suggests a Role in Tissue Proliferation Rather than in Neurotransmission
byMatteo Bozzo,Emanuele Serafini,Giacomo Rosa,Virginia Bazzurro,Andrea Amaroli,Sara Ferrando,Michael Schubert andSimona Candiani
Cells2025,14(14), 1071; https://doi.org/10.3390/cells14141071 (registering DOI) - 13 Jul 2025
Abstract
Serine hydroxymethyltransferases (SHMTs) are key enzymes in one-carbon metabolism, with vertebrates possessing two paralogs, cytosolic SHMT1 and mitochondrial SHMT2, implicated in nucleotide biosynthesis and glycine metabolism. In this study, we investigate the evolutionary history of animalShmt genes and analyze the expression patterns [...] Read more.
Serine hydroxymethyltransferases (SHMTs) are key enzymes in one-carbon metabolism, with vertebrates possessing two paralogs, cytosolic SHMT1 and mitochondrial SHMT2, implicated in nucleotide biosynthesis and glycine metabolism. In this study, we investigate the evolutionary history of animalShmt genes and analyze the expression patterns ofShmt genes in developing amphioxus (Branchiostoma lanceolatum). Phylogenetic analyses indicate the presence ofShmt1 andShmt2 orthologs in deuterostomes, spiralians and placozoans, which is consistent with an ancientShmt gene duplication event predating bilaterian diversification. Gene expression analyses in developing amphioxus show thatShmt2 expression is confined to the somites and absent from neural tissues. In contrast,Shmt1 is broadly expressed across germ layers, but its transcription is restricted to tissues characterized by strong cell proliferation. Notably,Shmt1 expression in the nervous system does not match the distribution of glycinergic neuron populations, implying a negligible role in glycine neurotransmitter synthesis. Instead, the spatial correlation ofShmt1 expression with mitotically active domains suggests a primary function in nucleotide biosynthesis via one-carbon metabolism. These findings indicate that SHMTs predominantly support cell proliferation rather than neurotransmission in amphioxus.Full article
(This article belongs to the Special IssueMechanisms Underlying Cell Growth and Development)
Show Figures

Figure 1

17 pages, 6342 KiB  
Article
Regulation of Hindbrain Vascular Development byrps20 in Zebrafish
byXinyu Shen,Zhaozhi Wen,Shunze Deng,Yuxuan Qiu,Weijie Ma,Xinyue Dong,Jie Gong,Yu Zhang,Dong Liu andBing Xu
Cells2025,14(14), 1070; https://doi.org/10.3390/cells14141070 (registering DOI) - 13 Jul 2025
Abstract
During aging, the brain vasculature undergoes significant deterioration characterized by increased arterial tortuosity, compromised blood–brain barrier integrity, and reduced cerebral blood flow, all of which contribute to various neurological disorders. Thus, understanding the mechanisms underlying aging-related cerebrovascular defects is critical for developing strategies [...] Read more.
During aging, the brain vasculature undergoes significant deterioration characterized by increased arterial tortuosity, compromised blood–brain barrier integrity, and reduced cerebral blood flow, all of which contribute to various neurological disorders. Thus, understanding the mechanisms underlying aging-related cerebrovascular defects is critical for developing strategies to alleviate aging-associated neurological diseases. In this study, we investigated the role of aging-related genes in brain vascular development using zebrafish as an in vivo model. By thoroughly analyzing scRNA-seq datasets of mid- and old-aged brain vascular endothelial cells (human/mouse), we foundribosomal protein S20 (rps20) significantly down-regulated during aging. qPCR analysis and whole-mount in situ hybridization validated a high expression ofrps20 during early zebrafish development, which progressively decreased in adult and aged zebrafish brains. Functional studies using the CRISPR/Cas9-mediated knockout ofrps20 revealed an impaired growth of central arteries in the hindbrain and a marked increased intracranial hemorrhage incidence. Mechanistically, qPCR analysis demonstrated a significant downregulation ofvegfa, cxcl12b, and cxcr4a, key signaling molecules required for hindbrain vascular development, inrps20-deficient embryos. In conclusion, our findings demonstrate thatrps20 is essential for proper brain vascular development and the maintenance of vascular homeostasis in zebrafish, revealing a novel mechanism by which aging-related genes regulate brain vascular development. This study provides new insights that may aid in understanding and treating aging-associated vascular malformations and neurological pathologies.Full article
Show Figures

Figure 1

16 pages, 520 KiB  
Review
Alzheimer’s Disease–Thrombosis Comorbidity: A Growing Body of Evidence from Patients and Animal Models
byJoanna Koch-Paszkowski,Christopher Sennett andGiordano Pula
Cells2025,14(14), 1069; https://doi.org/10.3390/cells14141069 (registering DOI) - 12 Jul 2025
Abstract
Background/Objectives: A growing body of evidence is amassing in the literature suggesting a correlation between Alzheimer’s disease (AD) and thrombotic vascular complications, which led to the suggestive hypothesis that thrombosis may contribute to AD onset and progression by damaging the neurovasculature and reducing [...] Read more.
Background/Objectives: A growing body of evidence is amassing in the literature suggesting a correlation between Alzheimer’s disease (AD) and thrombotic vascular complications, which led to the suggestive hypothesis that thrombosis may contribute to AD onset and progression by damaging the neurovasculature and reducing the cerebral blood flow. In turn, low cerebral blood flow is likely to contribute to neurodegeneration by reducing nutrient and oxygen supply and impairing toxic metabolite removal from the brain tissue. Methods: We searched the literature for studies in animal models of AD or patients diagnosed with the disease that reported circulating markers of platelet hyperactivity or hypercoagulation, or histological evidence of brain vascular thrombosis. Results: Platelet hyperactivity and hypercoagulability have been described in multiple animal models of AD, and histological evidence of neurovascular thrombosis has also been reported. Similarly, clinical studies on patients with AD showed circulating markers of platelet hyperactivity and hypercoagulation, or histological evidence of neurovascular thrombosis collected from post-mortem brain tissue samples. Conclusions: Taken together, a convincing picture is emerging that suggests a strong correlation between systemic or neurovascular thrombosis and AD. Nonetheless, a mechanistic role for haemostasis dysregulation and neurovascular damage in the onset or the progression of AD remains to be proven. Future research should focus on this important question in order to clarify the mechanisms underlying AD and identify a treatment for this disease.Full article
Show Figures

Figure 1

14 pages, 1377 KiB  
Article
miR-302a/b/d-3p Differentially Expressed During Frontonasal Development Is Sensitive to Retinoic Acid Exposure
byChihiro Iwaya,Akiko Suzuki,Goo Jun andJunichi Iwata
Cells2025,14(14), 1068;https://doi.org/10.3390/cells14141068 - 11 Jul 2025
Abstract
Any failure in frontonasal development can lead to malformations at the middle facial region, such as frontonasal dysplasia, midfacial clefts, and hyper/hypotelorism. Various environmental factors influence morphogenesis through epigenetic regulations, including the action of noncoding microRNAs (miRNAs). However, it remains unclear how miRNAs [...] Read more.
Any failure in frontonasal development can lead to malformations at the middle facial region, such as frontonasal dysplasia, midfacial clefts, and hyper/hypotelorism. Various environmental factors influence morphogenesis through epigenetic regulations, including the action of noncoding microRNAs (miRNAs). However, it remains unclear how miRNAs are involved in the frontonasal development. In our analysis of publicly available miRNA-seq and RNA-seq datasets, we found that miR-28a-5p, miR-302a-3p, miR-302b-3p, and miR-302d-3p were differentially expressed in the frontonasal process during embryonic days 10.5 to 13.5 (E10.5–E13.5) in mice. Overexpression of these miRNAs led to a suppression of cell proliferation in cultured mouse embryonic frontonasal mesenchymal (MEFM) cells as well as in O9-1 cells, a cranial neural crest cell line. Through advanced bioinformatic analyses and miRNA-gene regulation assays, we identified that miR-28a-5p regulated a total of 25 genes, miR-302a-3p regulated 23 genes, miR-302b-3p regulated 22 genes, and miR-302d-3p regulated 20 genes. Notably, the expression of miR-302a/b/d-3p—unlike miR-28a-5p—was significantly upregulated by excessive exposure toall-trans retinoic acid (atRA) that induces craniofacial malformations. Inhibition of these miRNAs restored the reduced cell proliferation caused byatRA by normalizing the expression of target genes associated with frontonasal anomalies. Therefore, our findings suggest that miR-302a/b/d-3p plays a crucial role in the development of frontonasal malformations.Full article
22 pages, 2521 KiB  
Article
Assessment of Feasibility of the M2 Macrophage-Based Adoptive Gene Transfer Strategy for Osteoarthritis with a Mouse Model
byMatilda H.-C. Sheng,David J. Baylink,Charles H. Rundle andKin-Hing William Lau
Cells2025,14(14), 1067;https://doi.org/10.3390/cells14141067 - 11 Jul 2025
Abstract
Current osteoarthritis (OA) therapies fail to yield long-term clinical benefits, due in part to the lack of a mechanism for the targeted and confined delivery of therapeutics to OA joints. This study evaluates if M2 macrophages are effective cell vehicles for the targeted [...] Read more.
Current osteoarthritis (OA) therapies fail to yield long-term clinical benefits, due in part to the lack of a mechanism for the targeted and confined delivery of therapeutics to OA joints. This study evaluates if M2 macrophages are effective cell vehicles for the targeted and confined delivery of therapeutic genes to OA joints. CT bioluminescence in vivo cell tracing and fluorescent microscopy reveal that intraarticularly injected M2 macrophages were recruited to and retained at inflamed synovia. The feasibility of an M2 macrophage-based adoptive gene transfer strategy for OA was assessed using IL-1Ra as the therapeutic gene in a mouse tibial plateau injury model. Mouse M2 macrophages were transduced with lentiviral vectors expressing IL-1Ra or GFP. The transduced macrophages were intraarticularly injected into injured joints at 7 days post-injury and OA progression was monitored with plasma COMP and histology at 4 weeks. The IL-1Ra-expressing M2 macrophage treatment reduced plasma COMP, increased the area and width of the articular cartilage layer, decreased synovium thickness, and reduced the OARSI OA score without affecting the osteophyte maturity and meniscus scores when compared to the GFP-expressing M2 macrophage-treated or PBS-treated controls. When the treatment was given at 5 weeks post-injury, at which time OA should have developed, the IL-1Ra-M2 macrophage treatment also reduced plasma COMP, had a greater articular cartilage area and width, decreased synovial thickness, and reduced the OARSI OA score without an effect on the meniscus and osteophyte maturity scores at 8 weeks post-injury. In conclusion, the IL-1Ra-M2 macrophage treatment, given before or after OA was developed, delayed OA progression, indicating that the M2 macrophage-based adoptive gene transfer strategy for OA is tenable.Full article
(This article belongs to the SectionCell and Gene Therapy)
Show Figures

Figure 1

32 pages, 1368 KiB  
Review
Calcium Unified: Understanding How Calcium’s Atomic Properties Impact Human Health
byKaren B. Kirkness,John Sharkey andSuzanne Scarlata
Cells2025,14(14), 1066;https://doi.org/10.3390/cells14141066 - 11 Jul 2025
Abstract
Calcium plays a major role in all cellular functions, and its regulation is important in all aspects of human health. This key role calcium plays in cell function can be traced to its unique molecular coordination geometry, which is often overlooked in understanding [...] Read more.
Calcium plays a major role in all cellular functions, and its regulation is important in all aspects of human health. This key role calcium plays in cell function can be traced to its unique molecular coordination geometry, which is often overlooked in understanding calcium function. In this review, we integrate calcium’s ability to form various complexes with proteins and small molecules with its role as a key signaling atom. We argue that calcium’s ability to vary its coordination structures, compared to magnesium’s rigid geometry, explains its importance in biological functions. By examining calcium-mediated proteins, such as those containing EF-hand domains and those that assemble and stabilize the extracellular matrix in tissue organization, we demonstrate how calcium’s varied geometric coordination serves as both a signaling molecule and a regulator of physiological homeostasis.Full article
(This article belongs to the SectionCell Microenvironment)
21 pages, 4829 KiB  
Article
Temporal and Severity-Dependent Alterations in Plasma Extracellular Vesicle Profiles Following Spinal Cord Injury
byJamie Cooper,Scott Tait Airey,Eric Patino,Theo Andriot,Mousumi Ghosh andDamien D. Pearse
Cells2025,14(14), 1065;https://doi.org/10.3390/cells14141065 - 11 Jul 2025
Abstract
Spinal cord injury (SCI) triggers both local and systemic pathological responses that evolve over time and differ with injury severity. Small extracellular vesicles (sEVs), known mediators of intercellular communication, may serve as biomarkers reflecting these complex dynamics. In this study, we investigated whether [...] Read more.
Spinal cord injury (SCI) triggers both local and systemic pathological responses that evolve over time and differ with injury severity. Small extracellular vesicles (sEVs), known mediators of intercellular communication, may serve as biomarkers reflecting these complex dynamics. In this study, we investigated whether SCI severity modulates the composition and abundance of circulating plasma-derived sEVs across subacute and chronic phases. Using a graded thoracic contusion model in mice, plasma was collected at defined timepoints post-injury. sEVs were isolated via size-exclusion chromatography and characterized using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and MACSPlex surface marker profiling. We observed an SCI-dependent increase in sEVs during the subacute (7 days) phase, most notably in moderate injuries (50 kdyne), with overall vesicle counts lower chronically (3 months). CD9 emerged as the predominant tetraspanin sEV marker, while CD63 and CD81 were generally present at low levels across all injury severities and timepoints. Surface sEV analysis revealed dynamic regulation of CD41+, CD44+, and CD61+ in the CD9+ sEV subset, suggesting persistent systemic signaling activity. These markers, traditionally associated with platelet function, may also reflect immune or reparative responses following SCI. Our findings highlight the evolving nature of sEV profiles after SCI and support their potential as non-invasive biomarkers for monitoring injury progression.Full article
(This article belongs to the Special IssueExtracellular Vesicles as Biomarkers for Human Disease)
Show Figures

Figure 1

39 pages, 1388 KiB  
Review
Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress
bySarah Reed,Equar Taka,Selina Darling-Reed andKaram F. A. Soliman
Cells2025,14(14), 1064;https://doi.org/10.3390/cells14141064 - 11 Jul 2025
Abstract
Epidemiological studies have shown that individuals with type 2 diabetes have an increased risk of developing neurodegenerative diseases. These diseases and type 2 diabetes share several risk factors. Meanwhile, the antidiabetic drug metformin offers promising neuroprotective effects by reducing oxidative stress and neuroinflammation, [...] Read more.
Epidemiological studies have shown that individuals with type 2 diabetes have an increased risk of developing neurodegenerative diseases. These diseases and type 2 diabetes share several risk factors. Meanwhile, the antidiabetic drug metformin offers promising neuroprotective effects by reducing oxidative stress and neuroinflammation, two significant factors in neurodegenerative diseases. This review examines the mechanisms by which metformin mitigates neuronal damage. Metformin reduces neuroinflammation by inhibiting microglial activation and suppressing proinflammatory cytokines. It also triggers the nuclear factor erythroid-2-related factor-2 (Nrf2) pathway to combat oxidative stress, an essential regulator of antioxidant defenses. These outcomes support the possible neuroprotective roles of metformin in type 2 diabetes-related cognitive decline and conditions like Alzheimer’s disease. Metformin’s therapeutic potential is further supported by its capacity to strengthen the blood–brain barrier’s (BBB’s) integrity and increase autophagic flux. Metformin also offers several neuroprotective effects by targeting multiple pathological pathways. Moreover, metformin is being studied for its potential benefits beyond glycemic control, particularly in the areas of cognition, Alzheimer’s disease, aging, and stroke management. Evidence from both clinical and preclinical studies indicates a complex and multifaceted impact, with benefits varying among populations and depending on underlying disease conditions, making it an appealing candidate for managing several neurodegenerative diseases.Full article
Show Figures

Figure 1

31 pages, 1549 KiB  
Systematic Review
Impact of Early-Life Brain Injury on Gut Microbiota Composition in Rodents: Systematic Review with Implications for Neurodevelopment
byVanessa da Silva Souza,Raul Manhães-de-Castro,Sabrina da Conceição Pereira,Beatriz Souza de Silveira,Caio Matheus Santos da Silva Calado,Henrique José Cavalcanti Bezerra Gouveia,Jacques-Olivier Coq andAna Elisa Toscano
Cells2025,14(14), 1063;https://doi.org/10.3390/cells14141063 - 11 Jul 2025
Abstract
Early-life brain injuries are major causes of long-term neurodevelopmental disorders such as cerebral palsy. Emerging evidence suggests these injuries can alter the gut microbiota composition, intestinal integrity, and neuroinflammatory responses. This systematic review evaluated the impact of early-life brain injuries on the gut [...] Read more.
Early-life brain injuries are major causes of long-term neurodevelopmental disorders such as cerebral palsy. Emerging evidence suggests these injuries can alter the gut microbiota composition, intestinal integrity, and neuroinflammatory responses. This systematic review evaluated the impact of early-life brain injuries on the gut microbiota in rodent models. A scientific literature search was conducted across Medline/PubMed, Web of Science, Scopus, and Embase. Initially, 7419 records were identified, and 21 eligible studies were included. Eligible studies focused on evaluating the microbiota alterations and related gut–brain axis markers at the neonatal or post-weaning stages. The data extraction and synthesis followed PRISMA guidelines. Most studies reported gut dysbiosis characterized by a decreased abundance of Bacteroidetes, andLactobacillus. Alterations were associated with an increased gut permeability, reduced tight junction proteins, and elevated pro-inflammatory cytokines. Several studies showed reduced levels of short-chain fatty acids and metabolic pathway disruptions. Brain outcomes included neuroinflammation, white matter injury, altered gene expression, and impaired structural integrity. These results suggest that early-life brain injury induces complex alterations in the gut microbiota and its metabolic products, which may contribute to systemic and neuroinflammatory processes. Understanding these interactions offers insights into the pathophysiology of neurodevelopmental disorders and highlights the gut–brain axis as a potential target for early interventions.Full article
Show Figures

Figure 1

20 pages, 2995 KiB  
Article
Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System
byShivaprasad H. Sathyanarayana,Sarah B. Spracklin,Sophie J. Deharvengt,Donald C. Green,Margery D. Instasi,Torrey L. Gallagher,Parth S. Shah andGregory J. Tsongalis
Cells2025,14(14), 1062;https://doi.org/10.3390/cells14141062 - 11 Jul 2025
Abstract
Circulating cell-free DNA (cfDNA) is an important biomarker for various cancer types, enabling a non-invasive testing approach. However, pre-analytical variables, including sample collection, tube type, processing conditions, and extraction methods, can significantly impact the yield, integrity, and overall quality of cfDNA. This study [...] Read more.
Circulating cell-free DNA (cfDNA) is an important biomarker for various cancer types, enabling a non-invasive testing approach. However, pre-analytical variables, including sample collection, tube type, processing conditions, and extraction methods, can significantly impact the yield, integrity, and overall quality of cfDNA. This study presents a comprehensive analytical validation of a magnetic bead-based, high-throughput cfDNA extraction system, with a focus on assessing its efficiency, reproducibility, and compatibility with downstream molecular applications. The validation was performed using a range of sample types: synthetic cfDNA spiked into DNA-free plasma, multi-analyte ctDNA plasma controls, Seraseq ctDNA reference material in a plasma-like matrix, extraction specificity controls, residual clinical specimen from patients, and samples from healthy individuals stored at room temperature or 4 °C for up to 48 h to assess stability. Extracted cfDNA was analyzed for concentration, percentage, and fragment size, using the Agilent TapeStation. Variant detection was evaluated using a next-generation sequencing (NGS) assay on the Seraseq ctDNA reference material. The results demonstrated high cfDNA recovery rates, consistent fragment size distribution (predominantly mononucleosomal and dinucleosomal), minimal genomic DNA (gDNA) contamination, and strong concordance between detected and expected variants in reference materials. The workflow also showed robust performance under different study parameters, variable sample conditions, including sample stability and integrity. Together, these findings confirm the efficiency and reliability of the evaluated cfDNA extraction system and underscore the importance of standardized pre-analytical workflows for the successful implementation of liquid biopsy for early cancer detection, therapeutic monitoring, and improved patient outcomes.Full article
(This article belongs to the Special IssueCurrent Status and Future Challenges of Liquid Biopsy)
Show Figures

Figure 1

28 pages, 3018 KiB  
Review
The Role of Neurohypophysial Hormones in the Endocrine and Paracrine Control of Gametogenesis in Fish
byMaya Zanardini andHamid R. Habibi
Cells2025,14(14), 1061;https://doi.org/10.3390/cells14141061 - 10 Jul 2025
Abstract
Arginine vasopressin (AVP) and oxytocin (OXT) are neuropeptides traditionally recognized for their roles in the control of osmoregulation, blood pressure, lactation, and parturition in mammals. However, growing evidence suggests that AVPand OXT also regulate gonadal functions in teleost fish. Their expression in both [...] Read more.
Arginine vasopressin (AVP) and oxytocin (OXT) are neuropeptides traditionally recognized for their roles in the control of osmoregulation, blood pressure, lactation, and parturition in mammals. However, growing evidence suggests that AVPand OXT also regulate gonadal functions in teleost fish. Their expression in both male and female gonads, the presence of their receptors in ovaries and testes, and their interactions with steroids and other gonadal factors indicate a role in modulating gametogenesis and steroidogenesis via autocrine and paracrine mechanisms. Here, we review the current findings on AVP and OXT in teleost gonads, compared to the observed functions in mammals, emphasizing their systemic interactions within the hypothalamic–pituitary–gonadal (HPG) axis. While highlighting the roles of gonadal AVP and OXT in fish reproduction, we underscore the need for further research to unravel their complex multifactorial regulatory networks. Insights into the vasopressinergic system could enhance aquaculture practices by improving spawning success and reproductive efficiency.Full article
(This article belongs to the SectionReproductive Cells and Development)
Show Figures

Figure 1

19 pages, 886 KiB  
Review
A Meta-Review of Spatial Transcriptomics Analysis Software
byJessica Gillespie,Maciej Pietrzak,Min-Ae Song andDongjun Chung
Cells2025,14(14), 1060;https://doi.org/10.3390/cells14141060 - 10 Jul 2025
Abstract
Spatial transcriptomics combines gene expression data with spatial coordinates to allow for the discovery of detailed RNA localization, study development, investigating the tumor microenvironment, and creating a tissue atlas. A large range of spatial transcriptomics software is available, with little information on which [...] Read more.
Spatial transcriptomics combines gene expression data with spatial coordinates to allow for the discovery of detailed RNA localization, study development, investigating the tumor microenvironment, and creating a tissue atlas. A large range of spatial transcriptomics software is available, with little information on which may be better suited for particular datasets or computing environments. A review was conducted to detail the useful metrics when choosing appropriate software for spatial transcriptomics analysis. Specifically, the results from benchmarking studies that compared software across four key areas of spatial transcriptomics analysis (tissue architecture identification, spatially variable gene discovery, cell–cell communication analysis, and deconvolution) were assimilated into a single review that can serve as guidance when choosing potential spatial transcriptomics analysis software.Full article
Show Figures

Figure 1

23 pages, 1259 KiB  
Review
Integrative Review of Molecular, Metabolic, and Environmental Factors in Spina Bifida and Congenital Diaphragmatic Hernia: Insights into Mechanisms and Emerging Therapeutics
byAngelika Buczyńska,Iwona Sidorkiewicz,Przemysław Kosiński,Adam Jacek Krętowski andMonika Zbucka-Krętowska
Cells2025,14(14), 1059;https://doi.org/10.3390/cells14141059 - 10 Jul 2025
Abstract
Spina Bifida (SB) and Congenital Diaphragmatic Hernia (CDH) are complex congenital anomalies that pose significant challenges in pediatric healthcare. This review synthesizes recent advancements in understanding the genetic, metabolic, and environmental factors contributing to these conditions, with the aim of integrating mechanistic insights [...] Read more.
Spina Bifida (SB) and Congenital Diaphragmatic Hernia (CDH) are complex congenital anomalies that pose significant challenges in pediatric healthcare. This review synthesizes recent advancements in understanding the genetic, metabolic, and environmental factors contributing to these conditions, with the aim of integrating mechanistic insights into therapeutic innovations. In SB, key findings highlight the roles ofKCND3, a critical regulator of spinal cord development, andVANGL2, essential for planar cell polarity and neural tube closure. MicroRNAs such as miR-765 and miR-142-3p are identified as key regulators of these genes, influencing neural development. Additionally, telomere shortening—a marker of cellular senescence—alongside disruptions in folate metabolism and maternal nutritional deficiencies, significantly increases the risk of SB. These findings underscore the crucial role of telomere integrity in maintaining neural tissue homeostasis during embryonic development. For CDH, genetic deletions, including those on chromosome 15q26, and chromosomal abnormalities have been shown to disrupt lung and vascular development, profoundly impacting neonatal outcomes. MicroRNAs miR-379-5p and miR-889-3p are implicated in targeting essential genes such asIGF1 andFGFR2, which play pivotal roles in pulmonary function. Promising emerging therapies, including degradable tracheal plugs and fibroblast growth factor-based treatments, offer potential strategies for mitigating pulmonary hypoplasia and improving clinical outcomes. This review underscores the intricate interplay of genetic, metabolic, and environmental pathways in SB and CDH, identifying critical molecular targets for diagnostics and therapeutic intervention. By integrating findings from genetic profiling, in vitro models, and clinical studies, it aims to inform future research directions and optimize patient outcomes through collaborative, multidisciplinary approaches.Full article
Show Figures

Figure 1

18 pages, 3083 KiB  
Article
Hypergravity and ERK Inhibition Combined Synergistically Reduce Pathological Tau Phosphorylation in a Neurodegenerative Cell Model
byValerio Mignucci,Ivana Barravecchia,Davide De Luca,Giacomo Siano,Cristina Di Primio,Jack J. W. A. van Loon andDebora Angeloni
Cells2025,14(14), 1058;https://doi.org/10.3390/cells14141058 - 10 Jul 2025
Abstract
This study evaluates the effects of hypergravity (HG) on a neurodegenerative model in vitro, looking at how HG influences Tau protein aggregation in Mouse Hippocampal Neuronal Cells (HT22) induced by neurofibrillary tangle seeds. Overall, 50×g significantly, synergistically, reduced the Tau aggregate Area [...] Read more.
This study evaluates the effects of hypergravity (HG) on a neurodegenerative model in vitro, looking at how HG influences Tau protein aggregation in Mouse Hippocampal Neuronal Cells (HT22) induced by neurofibrillary tangle seeds. Overall, 50×g significantly, synergistically, reduced the Tau aggregate Area when combined with ERK-inhibitor PD-0325901, correlating with decreased phosphorylation at critical residues pS262 and pS396. These findings suggest HG treatments may help mitigate cytoskeletal damage linked to Tau aggregation.Full article
(This article belongs to the Special IssueAgeing and Neurodegenerative Diseases, Second Edition)
Show Figures

Figure 1

47 pages, 2757 KiB  
Review
Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies
byDominika Kunachowicz,Paulina Tomecka,Mikołaj Sędzik,Jarosław Kalinin,Jacek Kuźnicki andNina Rembiałkowska
Cells2025,14(14), 1057;https://doi.org/10.3390/cells14141057 - 10 Jul 2025
Abstract
Hypoxia, characterized by a reduction in tissue oxygen levels, is a hallmark of many solid tumors and affects a range of cellular processes, including DNA repair. In low-oxygen conditions, cancer cells often suppress key DNA repair pathways such as homologous recombination (HR), leading [...] Read more.
Hypoxia, characterized by a reduction in tissue oxygen levels, is a hallmark of many solid tumors and affects a range of cellular processes, including DNA repair. In low-oxygen conditions, cancer cells often suppress key DNA repair pathways such as homologous recombination (HR), leading to the accumulation of DNA damage and increased genomic instability. These changes not only drive tumor progression but also contribute to resistance against conventional therapies. Hypoxia significantly reduces the effectiveness of oxygen-dependent treatments, including radiotherapy and many chemotherapeutic agents. To address this limitation, bioreductive drugs have been developed that become selectively activated in hypoxic environments, providing targeted cytotoxic effects within oxygen-deprived tumor regions. Additionally, the rapid growth of tumors often results in disorganized and inefficient vasculature, further impairing the delivery of oxygen and therapeutic agents. This review explores the molecular mechanisms by which hypoxia disrupts DNA repair and contributes to treatment resistance. It also presents emerging therapeutic strategies aimed at targeting the hypoxic tumor microenvironment to improve treatment efficacy and patient outcomes.Full article
(This article belongs to the SectionCell Microenvironment)
Show Figures

Figure 1

15 pages, 548 KiB  
Article
The Role of Cytokine Gene Polymorphisms in Rehabilitation Outcome After Traumatic Brain Injury
byFranca Rosa Guerini,Cristina Agliardi,Milena Zanzottera,Antonio Caronni,Laura Antolini,Chiara Camilla Derchi,Tiziana Atzori,Elisabetta Bolognesi,Jorge Navarro,Mario Clerici andAngela Comanducci
Cells2025,14(14), 1056;https://doi.org/10.3390/cells14141056 - 10 Jul 2025
Abstract
Traumatic brain injury (TBI) affects millions of people worldwide and often results in long-term disabilities. Clinical outcomes vary widely even among patients with similar injury severity, partly due to systemic neuroinflammatory responses mediated by pro- and anti-inflammatory cytokines. Genetic polymorphisms in cytokine-coding genes [...] Read more.
Traumatic brain injury (TBI) affects millions of people worldwide and often results in long-term disabilities. Clinical outcomes vary widely even among patients with similar injury severity, partly due to systemic neuroinflammatory responses mediated by pro- and anti-inflammatory cytokines. Genetic polymorphisms in cytokine-coding genes may influence cytokine expression, thereby affecting rehabilitation and prognosis. We analyzed genetic polymorphisms in theTNF-α,IL-6,IL-6 receptor,IL-1β, andIL-10 genes in 28 subacute TBI patients undergoing rehabilitation. Clinical outcomes were assessed using the Glasgow Outcome Scale Extended (GOSE) and domain-specific scales for cognitive, motor, and functional recovery. Results were correlated with genetic profiles to identify potential predictive biomarkers. TheIL-6-174 (GG) andIL-6R 1073 (AA) genotypes correlated with worse GOSE scores (p = 0.02 andp = 0.01, respectively). Co-segregation ofIL-6-174 -IL-6R 1073 G-A alleles was linked to poorer outcomes (p = 0.01). Patients with theTNF-α-308 (GA) genotype showed less improvement in Barthel and Mobility scores (p = 0.001 andp = 0.01, respectively) and had a higher incidence of post-traumatic confusional state after rehabilitation (p = 0.03). Overall, theTNF-α-308(GA),IL-6 -174(GG), andIL-6R 1073(AA) genotypes negatively impact rehabilitation outcomes, likely due to their role in enhancing neuroinflammation. Larger studies are needed to develop personalized therapies tailored to genetic profiles, aiming to improve rehabilitation outcomes for TBI patients.Full article
(This article belongs to the Special IssueNeuroinflammation in Brain Health and Diseases)
Show Figures

Figure 1

24 pages, 6634 KiB  
Article
Integrated Management of Tomato Fusarium Wilt: Ultrastructure Insights into Zn Nanoparticles and Phytohormone Applications
byYasmin M. Heikal,Amal M. Albahi,Amal A. Alyamani,Hala M. Abdelmigid,Samia A. Haroun andHoda M. Soliman
Cells2025,14(14), 1055;https://doi.org/10.3390/cells14141055 - 10 Jul 2025
Abstract
Fusarium wilt (FW), induced byFusarium oxysporum, poses a significant threat to global tomato (Solanum lycopersicum L.) production, leading to substantial yield reduction. This study investigated the anatomical and ultrastructural responses of tomato leaves to FW infection and assessed the efficacy [...] Read more.
Fusarium wilt (FW), induced byFusarium oxysporum, poses a significant threat to global tomato (Solanum lycopersicum L.) production, leading to substantial yield reduction. This study investigated the anatomical and ultrastructural responses of tomato leaves to FW infection and assessed the efficacy of salicylic acid (SA), humic acid (HA), and zinc oxide nanoparticles (ZnO-NPs) as control and inducer agents. FW infection resulted in notable structural alterations, including decreased leaf blade and mesophyll thickness and increased Adaxial epidermal cell wall thickness, thereby disrupting the leaf structure. Also, it caused severe chloroplast damage, such as membrane detachment and a reduced count of starch granules, which could impair photosynthetic efficiency. The different treatments exhibited significant effectiveness in reversing these adverse effects, leading to increased thickness of the leaf blade, mesophyll, palisade, and spongy tissues and enhanced structural integrity. Furthermore, ultrastructural improvements included activated mitochondria, compact chloroplasts with increased numbers, and proliferation of plastoglobuli, indicating adaptive metabolic changes. Principal component analysis (PCA-biplot) highlighted the significant parameters distinguishing treatment groups, providing insights into trait-based differentiation. This study concluded the potential of SA, HA, and ZnO-NPs as sustainable solutions for managing Fusarium wilt and enhancing tomato plant resilience, thereby contributing to improved agricultural practices and food security.Full article
(This article belongs to the SectionPlant, Algae and Fungi Cell Biology)
Show Figures

Figure 1

14 pages, 586 KiB  
Review
Cues of Trained Immunity in Multiple Sclerosis Macrophages
byElisa Popa,Hélène Cheval andVioletta Zujovic
Cells2025,14(14), 1054;https://doi.org/10.3390/cells14141054 - 10 Jul 2025
Abstract
Multiple sclerosis (MS) is a complex autoimmune disease with both genetic and environmental influences, yet its underlying mechanisms remain only partially understood. In this review, we compile evidence suggesting that trained immunity—a form of innate immune memory—may play a crucial role in the [...] Read more.
Multiple sclerosis (MS) is a complex autoimmune disease with both genetic and environmental influences, yet its underlying mechanisms remain only partially understood. In this review, we compile evidence suggesting that trained immunity—a form of innate immune memory—may play a crucial role in the autoimmune component of MS. By examining key findings from immunology, neuroinflammation, and MS pathophysiology, we explore how innate immune cells, particularly monocytes and macrophages, could contribute to disease onset and progression through persistent pro-inflammatory responses. Understanding the impact of trained immunity in MS could open new avenues for therapeutic strategies targeting the innate immune system.Full article
(This article belongs to the SectionCells of the Nervous System)
Show Figures

Figure 1

14 pages, 862 KiB  
Review
Immune and Inflammatory Properties of Megakaryocytes
byShiv Vardan Singh,Audrey Lucerne andKatya Ravid
Cells2025,14(14), 1053;https://doi.org/10.3390/cells14141053 - 10 Jul 2025
Abstract
Megakaryocytes (MKs), which primarily develop in bone marrow (BM) from hematopoietic stem cells, are critical for platelet production. Beyond their well-established role in thrombopoiesis, MKs have been identified as important for BM niche maintenance, such as by supporting the growth and differentiation of [...] Read more.
Megakaryocytes (MKs), which primarily develop in bone marrow (BM) from hematopoietic stem cells, are critical for platelet production. Beyond their well-established role in thrombopoiesis, MKs have been identified as important for BM niche maintenance, such as by supporting the growth and differentiation of other cell types. Recently, megakaryopoiesis has been reported as yielding divergent subpopulations of MKs, as evidenced by single-cell RNA sequencing of lung, spleen, or BM resident MKs. Interestingly, these subpopulations constitute a significant proportion of “immune MKs” expressing various classical immune markers and capable of phagocytosing pathogens and contributing to antigen presentation. As such, MKs were also found to regulate inflammation, mainly by secreting various cytokines and chemokines to crosstalk with other cell types. The level and functional signature of these “immune MKs” were found to be altered in various pathological conditions, indicative of their purposeful values in health and diseases. In this review, we survey and highlight newly reported functional immune and inflammatory properties of MKs in health and in select pathologies.Full article
Show Figures

Figure 1

cells-logo

Journal Browser

Journal Browser

Highly Accessed Articles

E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Topics

Topic inBiomedicines,Biomolecules,Cancers,Cells,Hematology Reports,IJMS
Advances in Molecular Pathogenesis and Targeted Therapies for Multiple MyelomaTopic Editors: Chung Hoow Kok, Cindy H. S. Lee, Claudio Cerchione
Deadline: 20 July 2025
Topic inCancers,Medicines,Medical Sciences,Cells,Pharmaceuticals,Biology,Biologics
Advances in Anti-Cancer Drugs: 2nd EditionTopic Editors: Armando Varela-Ramirez, Elisa Robles-Escajeda, Blanca E. Ruiz-Medina, Patricia Talamás-Rohana, Rachid Skouta
Deadline: 31 August 2025
Topic inAnalytica,Metabolites,Toxins,Molecules,Cells,Chemosensors
Application of Analytical Technology in MetabolomicsTopic Editors: Preeti Chandra, Raúl G. Enríquez
Deadline: 31 October 2025
Topic inCells,Chemistry,IJMS,Molecules,Metabolites
Bioactive Compounds and Therapeutics: Molecular Aspects, Metabolic Profiles, and Omics Studies 2nd EditionTopic Editors: Michele Costanzo, Giovanni N. Roviello, Armando Cevenini
Deadline: 20 November 2025
loading...

Special Issues

Special Issue inCells
Advances in the Biogenesis, Biology, and Functions of Noncoding RNAsGuest Editor: Xinguo Chen
Deadline: 15 July 2025
Special Issue inCells
Gut Dysbiosis in Inflammatory DiseasesGuest Editor: Weiwei Liu
Deadline: 15 July 2025
Special Issue inCells
Novel Insights into Molecular Mechanisms and Therapy of AsthmaGuest Editor: Marco Caminati
Deadline: 15 July 2025
Special Issue inCells
Decoding Cancer Metabolism: Recent Insights and Future DirectionsGuest Editors: Parash Prasad, Snehasis R. Mishra
Deadline: 15 July 2025

Topical Collections

Topical Collection inCells
Rejuvenating, Geroprotective and Cytoprotective Activities of Natural and Synthetic Compounds: Proofs of Concept, Associated Mechanisms and ApplicationsCollection Editors: Gérard Lizard, Giuseppe Poli, Mohamed Hammami, Amira Zarrouk
Topical Collection inCells
Endothelial Cell Dysfunction and Multi-Organ Injury: From Molecular Mechanisms to Therapeutic InterventionsCollection Editors: Mingui Fu, Yisong Qian, Zhi-Sheng Jiang
Topical Collection inCells
Pathometabolism: Understanding Disease through MetabolismCollection Editors: Ferdinando Chiaradonna, Domenca Scumaci, Andre Wegner
Topical Collection inCells
Role of Stem Cells in Spinal Cord InjuriesCollection Editors: Kee D. Kim, Julius O. Ebinu
Cells, EISSN 2073-4409, Published by MDPI
RSSContent Alert

Further Information

Article Processing Charges Pay an Invoice Open Access Policy Contact MDPI Jobs at MDPI

Guidelines

For Authors For Reviewers For Editors For Librarians For Publishers For Societies For Conference Organizers

MDPI Initiatives

Sciforum MDPI Books Preprints.org Scilit SciProfiles Encyclopedia JAMS Proceedings Series

Follow MDPI

LinkedIn Facebook X
MDPI

Subscribe to receive issue release notifications and newsletters from MDPI journals

© 1996-2025 MDPI (Basel, Switzerland) unless otherwise stated
Terms and Conditions Privacy Policy
We use cookies on our website to ensure you get the best experience.
Read more about our cookieshere.
Accept
Back to TopTop
[8]ページ先頭

©2009-2025 Movatter.jp